Purchase Order 36C25226P0239

RLS (USA) Inc., a foreign-owned radiopharmacy company headquartered in Lake Mary, Florida, was awarded a firm fixed-price purchase order valued at $1,747,515.93 by the Department of Veterans Affairs' Veterans Integrated Service Network 12 (VISN 12) on March 1, 2026. The contract, with an ultimate completion date of February 28, 2031, will be performed in Lake Mary, Florida and covers the supply of unit dose radiopharmaceuticals to support nuclear medicine diagnostic imaging procedures at the Clement J. Zablocki VA Medical Center in Milwaukee, Wisconsin. The procurement encompasses approximately 43 line items of radiopharmaceutical products, including technetium-99m compounds, iodine-123 and iodine-131 capsules, indium-111 compounds, and ancillary services such as emergency after-hours delivery and weekend white blood cell labeling services. Deliverables must comply with USP 797, Nuclear Regulatory Commission, Department of Transportation, and FDA regulations, with the contractor providing up to five daily routine weekday deliveries and pickups at no additional charge.

This unrestricted acquisition with no set-aside designation was awarded based on RLS (USA) Inc.'s demonstrated technical capability, past performance with similar radiopharmaceutical services, competitive pricing, and delivery and support reliability. RLS (USA) Inc. has established itself as a critical supplier to the VA and Defense Health Agency, operating 31 radiopharmacy facilities across 18 states and currently maintaining multiple prime Indefinite Delivery Vehicles with the VA system. The award reflects the Government's continued confidence in the contractor's capacity to reliably deliver specialized, time-sensitive medical isotopes essential to nuclear medicine diagnostic and therapeutic services across the VA healthcare network.